159:
113:
22:
47:
81:
210:
188:
68:
176:
193:
147:
246:
164:
108:
135:
118:
241:
123:
91:
86:
205:
17:
96:
235:
222:
51:
67:
The following 18 pages are in this category, out of 18 total.
35:This category has only the following subcategory.
160:Norwich Pharmacal Co v Customs and Excise Comrs
8:
64:Pages in category "English civil procedure"
69:This list may not reflect recent changes
7:
114:Civil procedure in England and Wales
23:Civil procedure in England and Wales
82:American Cyanamid Co v Ethicon Ltd
73:
37:
29:
14:
211:Super-injunctions in English law
189:Review of Civil Litigation Costs
1:
177:Pleading (England and Wales)
263:
194:Rules of the Supreme Court
148:Injunctions in English law
48:Injunctions in English law
16:The main article for this
15:
165:Norwich Pharmacal order
109:Calderbank v Calderbank
136:Group litigation order
119:Civil Procedure Rules
124:Costs in English law
92:Arbitration Act 1996
87:Anton Piller order
206:Statement of case
254:
53:
262:
261:
257:
256:
255:
253:
252:
251:
247:Civil procedure
232:
231:
230:
229:
228:
227:
215:
198:
181:
169:
152:
140:
128:
101:
61:
60:
59:
58:
55:
54:
28:
27:
12:
11:
5:
260:
258:
250:
249:
244:
234:
233:
226:
225:
219:
216:
214:
213:
208:
202:
199:
197:
196:
191:
185:
182:
180:
179:
173:
170:
168:
167:
162:
156:
153:
151:
150:
144:
141:
139:
138:
132:
129:
127:
126:
121:
116:
111:
105:
102:
100:
99:
97:Asset freezing
94:
89:
84:
78:
75:
74:
65:
62:
57:
56:
46:
45:
42:
39:
38:
33:
30:
13:
10:
9:
6:
4:
3:
2:
259:
248:
245:
243:
240:
239:
237:
224:
221:
220:
217:
212:
209:
207:
204:
203:
200:
195:
192:
190:
187:
186:
183:
178:
175:
174:
171:
166:
163:
161:
158:
157:
154:
149:
146:
145:
142:
137:
134:
133:
130:
125:
122:
120:
117:
115:
112:
110:
107:
106:
103:
98:
95:
93:
90:
88:
85:
83:
80:
79:
76:
72:
70:
63:
49:
44:
43:
40:
36:
32:Subcategories
31:
25:
24:
19:
223:Tomlin order
66:
34:
21:
242:English law
236:Categories
18:category
52:(8 P)
20:is
238::
71:.
50:
218:T
201:S
184:R
172:P
155:N
143:I
131:G
104:C
77:A
41:I
26:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.